BIOMAT Database Logo BIOMAT Database Logo

[Late recurrence of ovarian carcinoma treated with endoxan]. 1976

T Przystasz

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T Przystasz
Ovarian carcinoma treated with cyclophosphamide (Endoxan).
September 1968, Singapore medical journal,
T Przystasz
[Surgery and endoxan therapy in ovarian carcinoma].
June 1971, Archiv fur Gynakologie,
T Przystasz
[Endoxan pretreatment in apparently inoperable ovarian carcinoma?].
March 1962, Geburtshilfe und Frauenheilkunde,
T Przystasz
[Case of lung carcinoma treated with massive intravenous administration of Endoxan].
May 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
T Przystasz
[Tissue reaction in ovarian carcinoma after cyclophosphamide (Endoxan) therapy].
January 1969, Pathologia et microbiologia,
T Przystasz
[Endoxan in ovarian cancer].
January 1974, Revista chilena de obstetricia y ginecologia,
T Przystasz
[Prolonged intraperitoneal chemotherapy of ovarian tumors with Endoxan].
January 1968, Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie,
T Przystasz
[Results of the treatment of ovarian cancer with Endoxan].
July 1962, Medizinische Klinik,
T Przystasz
Late recurrence in endometrial carcinoma.
February 1987, Cancer,
T Przystasz
Late Recurrence of Carcinoma of Breast.
October 1960, British medical journal,
Copied contents to your clipboard!